The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions ...
Jul 6, 2016
0
4
Scientists at the Johns Hopkins Kimmel Cancer Center and University of Melbourne report they have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of ...
Jul 6, 2016
0
103
Kataegis is a recently discovered phenomenon in which multiple mutations cluster in a few hotspots in a genome. The anomaly was previously found in some cancers, but it has been unclear what role kataegis plays in tumor development ...
Jun 30, 2016
0
59
Fujifilm Corporation is announcing the progress in a Phase I clinical trial of radioimmunotherapeutic anti-cancer agent FF-21101 in the United States in patients with advanced solid cancers. In imaging, tumor uptake of antibody ...
Jun 28, 2016
0
4
In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide ...
Jun 21, 2016
0
444
(HealthDay)—For patients with non-metastatic breast cancer, exercise is associated with reductions in the incidence of cardiovascular events, according to a study published online May 23 in the Journal of Clinical Oncology.
Jun 7, 2016
0
5
The National Comprehensive Cancer Network (NCCN) recommends that colorectal cancer (CRC) screening begin at age 50. This means that less is known about the occurrence of the disease in people under age 50. Unfortunately, ...
Jun 6, 2016
0
1
While increased screening continues to drive down overall colorectal cancer rates, the rate of colorectal cancer in patients under age 50 is increasing, and the disease is commonly more aggressive in these young patients. ...
Jun 4, 2016
0
4
Patients who don't respond to treatments that use their own immune cells to destroy tumors, called tumor infiltrating lymphocytes, share changes in mechanisms that switch genes on or off in those cells, according to study ...
Jun 4, 2016
0
7
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell lymphoma who have ...
May 24, 2016
0
8
